Quallent Pharmaceuticals Health LLC drugs

61 results
  • adalimumab-ryvk

    (adalimumab-ryvk)
    Quallent Pharmaceuticals Health LLC
    Adalimumab-ryvk is indicated for various conditions, including rheumatoid arthritis, juvenile idiopathic arthritis, psoriatic arthritis, ankylosing spondylitis, Crohn's disease, ulcerative colitis, plaque psoriasis, hidradenitis suppurativa, and non-infectious uveitis, aiming to reduce symptoms and inhibit disease progression.
  • ambrisentan

    (Ambrisentan)
    Quallent Pharmaceuticals Health LLC
    Ambrisentan tablets are indicated for treating pulmonary arterial hypertension (PAH) to improve exercise capacity and delay clinical deterioration. It is primarily studied in patients with WHO Functional Class II–III symptoms, mainly due to idiopathic or heritable PAH or PAH linked to connective tissue diseases.
  • bupropion hydrochloride xl - bupropion hydrochloride tablet, extended release

    (Bupropion Hydrochloride)
    Quallent Pharmaceuticals Health Llc
    Bupropion hydrochloride extended-release tablets (XL) are indicated for the treatment of major depressive disorder (MDD) and the prevention of seasonal affective disorder (SAD). Its efficacy has been established through multiple clinical studies for both indications.
  • carvedilol

    (Carvedilol)
    Quallent Pharmaceuticals Health LLC
    Carvedilol is indicated for treating mild-to-severe chronic heart failure, reducing cardiovascular mortality in stable patients post-myocardial infarction with left ventricular dysfunction, and managing essential hypertension, either alone or with other antihypertensives, particularly thiazide-type diuretics.